NEW YORK, May 3 (GenomeWeb News) - Syrrx announced today that it has received an Advanced Technology Program grant from the National Institute of Standards and Technology to develop nanoscale arrays for improving the crystallization of membrane proteins.
The grant is for $2 million over three years, according to the ATP website.
The technology that the San Diego-based company hopes to develop with the grant money involves using a regularly-repeating nanoscale pattern to induce crystallization. The company plans to conduct over 100,000 experiments and will subcontract Santa Clara, Calif.-based Parallel Synthesis Technologies to engineer the nanoscale surfaces.
The new technology could reduce drug development time and costs, according to Syrrx.